Drug information for VAPRISOL
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
INJECTABLE; INJECTION
20MG
Prescription
CONIVAPTAN HYDROCHLORIDE
conivaptan
ASTELLAS
22016
2008-11-03 Review
2007-03-07 Letter
2007-03-07 Label
INJECTABLE; IV (INFUSION)
20MG/4ML (5MG/ML)
Discontinued
CONIVAPTAN HYDROCHLORIDE
conivaptan
ASTELLAS
21697
2012-02-06 Label
2012-02-03 Letter
2010-06-03 Label
2010-06-02 Letter
2008-11-07 Label
2008-10-14 Letter
2006-03-24 Review
2006-01-06 Letter
2005-12-30 Label
Drug Adverse Effects information for VAPRISOL
Role code
Indications
Reaction
# Reports
PS
BLOOD SODIUM DECREASED
CARDIOMYOPATHY
2
PS
BLOOD SODIUM DECREASED
DEATH
2
PS
NAUSEA
CARDIOMYOPATHY
2
PS
NAUSEA
DEATH
2
PS
PRODUCT USED FOR UNKNOWN INDICATION
CARDIOMYOPATHY
32
PS
PRODUCT USED FOR UNKNOWN INDICATION
DEATH
34
PS
URINARY TRACT INFECTION
CARDIOMYOPATHY
2
PS
URINARY TRACT INFECTION
DEATH
2
Ads by Google